Literature DB >> 18417113

The (pro)renin receptor: a new addition to the renin-angiotensin system?

Wendy W Batenburg1, A H Jan Danser.   

Abstract

The renin-angiotensin system is still incompletely understood. In particular, the function of prorenin, the inactive precursor of renin, is unknown. Yet, prorenin levels are >10-fold higher than renin levels, and prorenin increases even further in subjects with diabetes mellitus displaying microvascular complications. The recent discovery of a (pro)renin binding receptor may shed light on the role of prorenin. This review discusses the possibility that prorenin binding to this receptor results in prorenin activation, thereby allowing angiotensin generation, and that prorenin simultaneously acts as an agonist of this receptor, inducing angiotensin-independent effects. Transgenic animals overexpressing the receptor, as well as a receptor antagonist are now available, and future studies should reveal to what degree this concept is applicable to humans as well.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18417113     DOI: 10.1016/j.ejphar.2008.02.092

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Limitations of angiotensin inhibition.

Authors:  Niloofar Nobakht; Mohammad Kamgar; Anjay Rastogi; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2011-04-19       Impact factor: 28.314

Review 2.  A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link?

Authors:  Adolfo E Cuadra; Zhiying Shan; Colin Sumners; Mohan K Raizada
Journal:  Pharmacol Ther       Date:  2009-08-31       Impact factor: 12.310

3.  Regulation of the (pro)renin-renin receptor in cardiac remodelling.

Authors:  Hasan Mahmud; Herman H W Silljé; Megan V Cannon; Wiek H van Gilst; Rudolf A de Boer
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

Review 4.  Three key proteases--angiotensin-I-converting enzyme (ACE), ACE2 and renin--within and beyond the renin-angiotensin system.

Authors:  Cuie Guang; Robert D Phillips; Bo Jiang; Franco Milani
Journal:  Arch Cardiovasc Dis       Date:  2012-06-15       Impact factor: 2.340

5.  Effect of add-on aliskiren to type 1 angiotensin receptor blocker therapy on endothelial function and autonomic nervous system in hypertensive patients with ischemic heart disease.

Authors:  Atsuko Ozeki; Eisuke Amiya; Masafumi Watanabe; Yumiko Hosoya; Munenori Takata; Aya Watanabe; Shuichi Kawarasaki; Tomoko Nakao; Shogo Watanabe; Kazuko Omori; Namie Yamada; Yukiko Tahara; Yasunobu Hirata; Ryozo Nagai
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-07-07       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.